Sigma-Aldrich Corp

  • Insiders Bought These Five Stocks Recently

    By Meena Krishnamsetty - February 21, 2013 | Tickers: BRE, KMX, MUR, NCT, SIAL

    We track insider purchases because we believe they serve as signals that company officers or Board members are confident in the stock’s prospects. This confidence has to be strong enough for an insider to ignore the benefits of diversification and actually increase their holdings of the stock. While insider purchases don’t always precede a rise in the stock price, on average stocks bought by insiders tend to outperform more »

  • A Senior VP Bought Shares of This Chemicals Company

    By Meena Krishnamsetty - February 20, 2013 | Tickers: LYB, PPG, SIAL, VAL, WLK

    George Miller, who serves as a senior vice president at $9.3 billion market cap chemicals and chemical equipment company Sigma-Aldrich (NASDAQ: SIAL), bought 1,000 shares of the stock on Feb. 15 at an average price of $76.92 per share according to a Form 4 filed with the SEC. It’s normally not rational for an insider to buy more shares of their company’s stock, so we more »

  • Becton Dickinson’s Expanding PEG Multiple

    By Steve Van - December 3, 2012 | Tickers: ABT, BAX, BDX, GLW, SIAL

    Regularly reviewing past opinions on stocks is a good habit for investors to develop because it helps to clarify what they got right and what they missed. Over time this habit, practiced consistently, will make for better investment decisions and better returns. In that spirit, I looked back at my post about Becton Dickinson (NYSE: BDX) from April 19. At the share price of $77 at that time, I concluded more »

  • The Safest Dividends in the World

    By Brian Shaw - September 9, 2012 | Tickers: AFL, CTAS, XOM, FDO, SIAL

    In a world of economic turmoil and low interest rates, investors are often looking for ways to generate solid returns with minimal risk.  Within the stock market, there is arguably no less risky pool of stocks than the 2012 list of dividend aristocrats, a group of 51 companies that have each increased dividend payments for at least 25 consecutive years.  I recently wrote about four of the newcomers to this more »

  • Sigma-Aldrich Dividend – Slowing or Growing?

    By Chad Henage - June 4, 2012 | Tickers: DD, SIAL, DOW

    If you are looking for a way to play the medical field, a good option would be Sigma-Aldrich (NASDAQ: SIAL). The company's chemicals and kits are used in scientific research, hospitals, labs, and universities. The company has been around for over 60 years, and doesn't show signs of slowing down. Sigma-Aldrich also has the distinction of being one of a handful of companies to have at least 25 straight years of dividend increases. Unfortunately we've seen in the last few years, just because a company has a good dividend record, doesn't mean things won't change. Keeping that in mind, let's run Sigma-Aldrich through a few tests to see how the company covers its current dividend, and to find out what to expect in the future.

  • J.P. Morgan Healthcare Conference Schedule: Day One

    By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ

    The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.

    I will be following (and covering) the novel therapeutic companies that have caught my eye. VIVUS (NASDAQ: VVUSmore »)